Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3936841000168112 | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3936851000168114 | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4100961000168112 | Katie-35 ED (cyproterone acetate 2 mg + ethinyloestradiol 35 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet | true | Inferred relationship | Some | ||
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | Katie-35 ED | true | Inferred relationship | Some | ||
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has unit of use | tablet | true | Inferred relationship | Some | 2123401256 | |
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has intended active ingredient | ethinylestradiol | true | Inferred relationship | Some | 752255328 | |
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has Australian BoSS | ethinylestradiol | true | Inferred relationship | Some | 752255328 | |
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has Australian BoSS | cyproterone acetate | true | Inferred relationship | Some | 2123401255 | |
| Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has intended active ingredient | cyproterone | true | Inferred relationship | Some | 2123401255 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TPUU | True | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | True | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | has TPUU | True | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs | has TPUU | True | Katie-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
Reference Sets
Trade product unit of use reference set
FHIR